A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.
FDA offers suite of new guidance on AI, accelerated approvals, clinical trials and more
With two weeks until President-elect Donald Trump’s administration takes over, the FDA on Monday released dozens of new draft and final guidance documents covering everything